Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nipah virus vaccine
- Development stage
- Unknown
- Lead developer
- AbVacc
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Nipah virus vaccine developed by AbVacc is a recombinant vesicular stomatitis virus (rVSV)-based viral vector vaccine designed to prevent Nipah virus infection. Nipah virus is a zoonotic pathogen that causes severe disease characterized by febrile encephalitis and severe respiratory distress. The vaccine platform utilizes a modified VSV vector to deliver Nipah virus antigens, thereby stimulating the host immune system to produce protective antibodies and cellular immune responses. According to company pipeline information, the candidate has progressed through discovery and preclinical IND-enabling studies and is currently in Phase 2 clinical development.
- Other names
- recombinant VSV-based Nipah vaccinerVSV-vectored Nipah vaccinerecombinant vesicular stomatitis virus (VSV)-based vaccine
Beyond the preview
Go deeper on Nipah virus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nipah virus vaccine.